Meylan, France

Jean-Luc Lenormand

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Centre Hospitalier Universitaire Grenoble Alpes, Establissement Francais Du Sang, Université Grenoble Alpes. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Luc Lenormand. Retrieved from https://idiyas.com/inventor/jean-luc-lenormand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Luc Lenormand

Introduction

Jean-Luc Lenormand is a notable inventor based in Meylan, France. He has made significant contributions to the field of medical science, particularly in the development of vaccines. His work focuses on innovative solutions to combat infections, especially in vulnerable patient populations.

Latest Patents

Jean-Luc Lenormand holds a patent for an "Attenuated strain of pseudomonas as a vaccine for pseudomonas infection." This patent describes a live-attenuated strain intended for use as a vaccine and in methods for preventive immunization and treatment of infections. This is particularly relevant for patients suffering from cystic fibrosis. The strain is designed to be 'killed but metabolically active,' enhancing its effectiveness as a vaccine.

Career Highlights

Throughout his career, Lenormand has been associated with prestigious institutions such as Université Grenoble Alpes and Centre Hospitalier Universitaire Grenoble Alpes. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Audrey Le Gouellec and Bertrand Toussaint. Their collaborative efforts have further advanced the research and development of innovative medical solutions.

Conclusion

Jean-Luc Lenormand's contributions to vaccine development highlight his commitment to improving healthcare outcomes for patients with cystic fibrosis. His innovative approach and dedication to research continue to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…